Influence of Nutritional Guidance/Consulting on Glycemic Control during the Coronavirus Disease 2019 Pandemic in Patients with Type 2 Diabetes Mellitus.

Abstract

Objective The coronavirus disease 2019 (COVID-19) pandemic has led to a global restriction of public behavior due to lockdowns in various major cities. Lifestyle changes and reduced rates of outpatient lifestyle guidance/consulting may have had some impact on glycemic control in patients with type 2 diabetes. This study analyzed the impact of changes in the frequency of nutritional guidance/consulting (NGC) during the COVID-19 pandemic on outpatient care for type 2 diabetes. Methods Among 785 patients, 67 who received regular NGC during the COVID-19 pandemic were assigned to the continuation group (CG), 143 whose NGC was discontinued after the pandemic were assigned to the discontinuation group (DG), and 575 who did not receive regular NGC regardless of the COVID-19 pandemic status were assigned to the irregular NGC group (IGG). The three groups were followed up for two years. Analyses among the three categories were performed using the chi-square test or an analysis of covariance. Results The number of diabetes medications after the declaration of the COVID-19 emergency did not markedly increase in the CG (2.0±1.4 to 2.1±1.5, p>0.05) but significantly increased from 2.2±1.4 to 2.6±1.4 in the DG (p<0.005) and from 2.2±1.4 to 2.4±1.4 in the IGG (p<0.005). The increase in HbA1c adjusted for confounders was unchanged at 0.12±1.06% for the CG and -0.07±1.29% for the IGG but was significantly increased at 0.19±1.49% for the DG (p<0.05). Conclusion In patients with type 2 diabetes mellitus, regular nutritional guidance may be important for maintaining good glycemic control, even during the COVID-19 pandemic.

• Authors: Yuichiro Iwamoto, Shuhei Nakanishi, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Tomohiko Kimura, Fuminori Tatsumi, Masashi Shimoda, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
• Journal: Internal medicine (Tokyo, Japan) (Intern Med) Vol. 62 Issue 6 Pg. 833-838 (Mar 15 2023) ISSN: 1349-7235 [Electronic] Japan
• PMID: 36631097 (Publication Type: Journal Article)

Chemical References

• Glycated Hemoglobin
• Immunoglobulin G

Topics

• Humans
• Diabetes Mellitus, Type 2 (epidemiology, drug therapy)
• COVID-19
• Pandemics
• Glycemic Control
• Glycated Hemoglobin
• Communicable Disease Control
• Immunoglobulin G (therapeutic use)